ConShield Exclusively Integrates SiShield Antimicrobial Solutions for Enhanced Protection against Microbial-Induced Corrosion in Sewer Infrastructure
ELK GROVE VILLAGE, Ill., Oct. 3, 2023 /PRNewswire/ — APM, one of the largest sewer protective additive companies in the United States, is excited to announce its exclusive partnership with SiShield Technologies, a creator of cutting-edge antimicrobial solutions, for its ConShield products. ConShield products protect sewer pipes from the rampant corrosion commonly observed in municipal sewers, identified as Microbial Induced Corrosion (MIC). MIC manifests when aerobic bacteria, mainly Thiobacillus, grow on concrete surfaces in wetted areas and above flow lines, converting O2 and H2S gas into sulfuric acid. This reaction leads to swift concrete dissolution. SiShield’s safe, effective, and sustainable antimicrobial formulations integrate seamlessly with ConShield products, creating an invisible protective seal that inhibits the growth of bacteria and other destructive microbes.
ConShield products fight sewer pipe degradation and contamination. As an EPA-registered antibacterial agent, ConShield prevents MIC by effectively inhibiting the growth of T. bacteria, often thriving in sanitary sewer structures. ConShield’s unique composition allows it to molecularly bond with the concrete matrix, permeating the entire thickness of the concrete, be it a pipe, manhole, liner, or poured structure. Unlike other treatments, ConShield cannot wash off, peel off, delaminate, or form pinholes, making it the most reliable, long-term protection solution for concrete in municipal sewers.
By partnering with SiShield, ConShield offers a fortified defense against the bacterial processes that produce harmful sulfuric acid in sewer systems. This collaboration ensures that the microbial processes, which have often been misunderstood as merely a “gas problem,” are addressed at their root, targeting the dangerous acid production when hydrogen sulfide gas interacts with Thiobacillus bacteria. Further, SiShield Technologies is committed to Sustainable Chemistry, and its water-based solutions are non-toxic, non-leaching, and do not harm the environment or people.
ConShield, known for its rigorous standards in sewer treatment, sees this partnership as a significant value-add for its customers and stakeholders, including pre-casters, municipalities, and Departments of Transportation. “SiShield’s innovative solutions integrate perfectly with ConShield’s technology, creating long-lasting, safe, and durable protection for sewers and manhole structures across the country,” said Harley B. Kaplan, CEO of Waterline Renewal Technologies, the parent company of APM. “Together, we can extend the life of concrete used in sewer applications and stop premature degradation.”
“Our partnership with APM and ConShield underlines our commitment to create a cleaner, safer, healthier world. Their reputation for excellence in infrastructure treatment complements our cutting-edge antibacterial solutions, ensuring a more resilient urban ecosystem,” said SiShield’s Chief Technology Officer, Greg Montello.
Together, ConShield and SiShield protect our municipal and private sewer infrastructures against relentless MIC threats. With ConShield, factors like temperature, effluent retention time, high biological oxygen demand levels, and turbulence – which often contribute to rapid bacterial growth – are now more effectively managed. As APM and SiShield continue to innovate and push boundaries, their shared goal remains clear: to provide communities with the safest and most effective to provide communities with the safest and most effective antimicrobial solutions to protect our infrastructure.
About Waterline Renewal Technologies:
Waterline Renewal Technologies is a leading provider of products, technologies, and services in the trenchless rehabilitation industry in the United States. We deliver trenchless rehabilitation of degraded infrastructure through differentiated products, technologies and services, to prevent inflow and infiltration of drain, sewer and stormwater systems. Waterline Renewal Technologies’ subsidiaries include APM (including product brands ConShield, CentriPipe and Permacast), LMK Technologies, Perma-Liner Industries, LightRay, and Pipe Lining Supply. Waterline Renewal Technologies Corporate Headquarters is in Elk Grove Village, IL with distribution facilities across the United States. To read more go to www.waterlinerenewal.com.
About SiShield Technologies:
SiShield Technologies is the industry-leading chemical technology company providing effective, durable, and safe antimicrobial solutions. SiShield specializes in the research, development, and manufacturing of science-based products that create an invisible, protective barrier. SiShield’s patented and EPA-registered formulations, integrated during the manufacturing process, have advanced the antimicrobial space, creating powerful, environmentally friendly products under its SiShield and Miracle Fresh ingredient brands.
SiShield partners with distributors and manufacturers across industries—including chemical additives, building material manufacturers, textiles, healthcare, and consumer goods—to develop customized solutions for our customers’ unique applications and needs. Based in Atlanta, Georgia, the company sources its materials in the United States, develops formulations in-house, and operates globally. For more information, please go to www.sishield.com.
For media inquiries, please contact:
Waterline Renewal Technologies Morgan Dietsch [email protected] (727) 422-4879
SAN DIEGO, Oct. 3, 2023 /PRNewswire/ — Attention, Taco enthusiasts! On October 4th, Epic Wings celebrates National Taco Day in epic style. Buy a 20oz Coca-Cola drink and Get a Free Chicken Taco. Order online, in-store, or on our app; use code FREETACO.
The Chicken Taco is next level. It’s their juicy tenderloin strip, tossed in your choice of sauce, topped with crispy coleslaw, and chipotle ranch. It’s an epic take on a classic favorite.
Starting 10/5, for a limited time grab a Taco Combo- 2 Tacos and a drink for $9.95. Crave some heat? Choose the new Atomic Reaper sauce; it’s a bold pick.
Epic Wings is renowned for its award-winning wings (voted the best in San Diego for 11 years running). Whether you prefer bone-in or boneless wings, you’re covered. Epic Wings offers original buffalo wings and tenderloin strips that are always fresh, never frozen. Meals come with homemade breadsticks, sauces, and dips. And don’t forget to try the standout Epic Fries!
Menu Faves
Single & Double Meals – Choose from Tenderloin Strips or Original Buffalo Wings served with carrots, celery, house-made dressings, and hot oven-fresh breadsticks.
Buffalo Sauces – Indulge in flavors ranging from Mild, Medium, Hot, and Atomic, and other flavors including Original BBQ, Garlic Parmesan, Honey BBQ, Lemon Pepper, and Sweet Chili.
Epic Chicken Taco – Bite into a boneless tenderloin strip, tossed in a choice of sauce, topped with crispy slaw & chipotle ranch.
Buffalo Pizza Sticks – Treat yourself to homemade breadsticks topped with signature buffalo sauce, melted cheese, and boneless chicken served with ranch for dipping.
Epic Fries – Dive into crispy fresh-cut fries with melted cheese and boneless buffalo chicken, finished with a chipotle-ranch dressing.
Epic Chicken Salad – Enjoy fresh romaine lettuce, green bell peppers, cherry tomatoes, cucumbers, red onion, and pepperoncini topped with chicken tossed in your choice of sauce.
ABOUT EPIC WINGS Epic Wings has been family-owned and operated since 1982. Formerly known as Wings N’ Things, the family was the first to bring Buffalo Wings to the West Coast. The menu features award-winning family recipes, including fresh, never frozen, original buffalo wings, tenderloin strips, pizza sticks, fries, salads, homemade bread sticks, and dips. With 35 locations and expansion into Illinois, Texas, and North Carolina, Epic Wings continues to uphold its 40-year legacy of serving exceptional wings.
AWARDS 2022- Entrepreneur Magazine “The 150 Hottest New Brands” – Ranked #7 2023-San Diego-Union Tribune Readers Poll – Voted Best Wings for eleven consecutive years 2002 & 2023-The California Press-Enterprise Readers’ Choice Award – Voted Best Wings Inland Empire. 2022 & 2023- Phoenix New Times Readers’ Poll – Voted Best Wings.
SOUTHAMPTON, N.Y., Oct. 3, 2023 /PRNewswire/ — Southampton’s iconic hot spot, 75 Main, received a complete interior renovation this year, courtesy of Bishop Design by Paul Bishop, the world-renowned design studio. Patrons have been buzzing over the new ambiance as they enjoyed their summer season at the restaurant.
Beloved locale 75 Main redesigned by Bishop Design
Shot of main dining room including tropical and traditional Hamptons-coastal elements
Photography credits: Jamon Davis
A Hamptons institution, 75 Main is led by seasoned restaurateur, Zach Erdem, known for his infectious charm and culinary passion, attracting a loyal clientele of local residents and A-list celebrities, including Jon Bon Jovi and Kim Kardashian. The venue also serves as the backdrop for the hit reality TV show, “Serving the Hamptons” documenting Erdem and his team during the vibrant summer seasons in the high-profile holiday destination.
As preparations for the third season’s filming were underway, (by streaming powerhouse, MAX), Erdem recognized the need for an overdue upgrade in the restaurant’s aesthetics. He turned to Bishop Design, a studio with a global reputation for creating groundbreaking hospitality venues. With over 200 international awards and collaborations with leading names such as Massimo Bottura and Dario Cecchini, Bishop was the natural choice for this legacy project.
Erdem explains, “Paul Bishop was my first choice, and the way he and his team created a ‘Tulum meets Hamptons’ vibe exceeded even my expectations!”
Bishop approached the assignment thoughtfully and respectfully, recognizing that building upon the restaurant’s history while transforming it was a delicate and essential balance. The infusion of tropical earthy tones, tribal patterns, and natural materials like wood, leather, ratan, and clay were combined with blue and white accents, white-washed shiplap wood, and a coffered ceiling. The result yielded a remarkable blend of airy Mayan vibes with a beautifully preserved Hamptons’ coastal feel.
“We saw 75 Main as more than an interior redesign, but an exciting opportunity to elevate and set a new benchmark for what a Hamptons space can look and feel like,” explains Paul Bishop, founder of Bishop Design.
The metamorphosis of 75 Main, skilfully combining sophistication with tropical charm, has ignited a sensation throughout Southampton this year. The resounding acclaim from both loyal patrons and newcomers has led owner Zach Erdem to proudly declare, “75 Main is now Long Island’s premier destination for exceptional design and experience, and for that, I must thank Bishop Design“.
HASTINGS, Mich., Oct. 3, 2023 /PRNewswire/ — The Viking Corporation announced today a new sprinkler to round out its robust residential concealed sprinkler offering. The cULus Listed VK495 K3.7 Residential Concealed Pendent provides sprinkler designers more options than ever before when dealing with the variability in water supplies seen in residential sprinkler systems.
“The low-flowing K3.7 sprinkler is optimized at the 14′ x 14′ coverage area flowing only 10 gpm at 7.3 psi,” states Darren Palmieri, Viking’s General Manager – Residential Portfolio. “The K3.7 fills out our residential concealed pendent line perfectly, as we already offer a K3.0, K4.9 and K5.8. We now offer concealed sprinklers that are optimized for all the most commonly used coverage areas, making Viking a one-stop-shop for sprinkler designers.”
Viking’s glass bulb VK495 is available in brass or an Electroless Nickel PTFE (ENT) coating for applications in which corrosion might be of concern. The sprinkler is cULus Listed and has an Ordinary temperature rating of 155°F (68°C) and an Intermediate temperature rating of 200°F (93°C). Its protective cap prevents damage to the sprinkler during installation and ceiling finishing, and Viking’s line of cover plates offers multiple sizes, finishes and shapes.
To learn more about Viking’s wide-ranging product line featuring industry-leading residential sprinkler solutions, visit vikinggroupinc.com or contact your local Viking SupplyNet.
Viking is a global leader in the manufacture and distribution of innovative fire protection and life safety systems. For more than 100 years the company’s products and services have protected lives and property worldwide from the devastating effects of fire. For more information on Viking’s complete line of fire protection products and services, please visit www.vikinggroupinc.com.
SYDNEY, Oct. 3, 2023 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) (“Clarity”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the dosing of the first patient in its theranostic 64Cu/67Cu SAR-Bombesin Phase I/II trial in metastatic castrate resistant prostate cancer (mCRPC). No issues were observed during the administration of 6GBq of 67Cu SAR-Bombesin and the participant continues to be followed for further safety and efficacy assessments as per protocol.
COMBAT, which derives from “Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and cohort expansion trial for up to 38 participants. 64Cu SAR-Bombesin is used to visualise gastrin-releasing peptide receptor (GRPr)-expressing lesions and select candidates for subsequent 67Cu SAR-Bombesin therapy. The aim for the trial is to determine the safety and efficacy of 67Cu SAR-Bombesin in participants with GRPr expressing mCRPC who are ineligible for therapy with 177Lu PSMA-617. These patients are unlikely to benefit from prostate-specific membrane antigen (PSMA)-targeted agents and represent a significant unmet need for both imaging and therapy. Doses of up to 14GBq of 67Cu SAR-Bombesin, in up to four cycles, are planned to be investigated in this trial (pending safety reviews).
Clarity’s Executive Chairperson, Dr Alan Taylor, commented, “SAR-Bombesin has already resulted in improvements to the management of prostate cancer for patients with PSMA-negative or low PSMA expressing lesions through diagnostic trials and we hope to confirm its safety and efficacy in this theranostic trial. We look forward to progressing the COMBAT trial and building on the compelling data from our preclinical and clinical studies to date. Combined with the logistical and manufacturing benefits of Targeted Copper Theranostics and with commercial quantities of the 67Cu radioisotope now being routinely produced domestically in the US, we see a clear path to bringing SAR-Bombesin and SAR-bisPSMA to the prostate cancer patient population in need of novel treatments.”
About SAR-Bombesin
SAR-Bombesin is a highly targeted pan-cancer radiopharmaceutical with broad cancer application. It targets the gastrin-releasing peptide receptor (GRPr) present on cells of a range of cancers, including but not limited to prostate, breast and ovarian cancers. GRPr is found in up to 100% of prostate cancers, including prostate cancers that don’t express PSMA (PSMA-negative)2-6. The product utilises Clarity’s proprietary sarcophagine (SAR) technology that securely holds copper isotopes inside a cage-like structure, called a chelator. Unlike other commercially available chelators, the SAR technology prevents copper leakage into the body. SAR-Bombesin is a Targeted Copper Theranostic (TCT) that can be used with isotopes of copper-64 (Cu-64 or 64Cu) for imaging and copper-67 (Cu-67 or 67Cu) for therapy.
64Cu SAR-Bombesin and 67Cu SAR-Bombesin are unregistered products. Individual results may not represent the overall safety and efficacy of the products. The data outlined in this announcement has not been assessed by health authorities such as the US Food and Drug Administration (FDA). A clinical development program is currently underway to assess the efficacy and safety of these products. There is no guarantee that these products will become commercially available.
About Prostate Cancer
Prostate cancer is the second most common cancer diagnosed in men globally and the fifth leading cause of cancer death worldwide7. The American Cancer Institute estimates in 2023 there will be 288,300 new cases of prostate cancer in the US and around 34,700 deaths from the disease8.
Approximately 25% of mCRPC patients have low or no uptake of a PSMA-targeting tracer.9 These patients are therefore unlikely to respond to therapeutic PSMA-targeted products and currently have few treatment options available to them. Given the prostate cancer indication is one of the largest in oncology, there is a significant unmet medical need in this segment. The SAR-Bombesin product could offer valuable imaging and therapeutic options for not only PSMA-negative patients, but also the large number of patients that have the target receptor on their cancers.
About Clarity Pharmaceuticals
Clarity is a clinical stage radiopharmaceutical company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceuticals, developing targeted copper theranostics based on its SAR Technology Platform for the treatment of cancer in children and adults.
2. Markwalder R, Reubi JC. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer research. 1999;59(5):1152-1159.
3. Fleischmann A, Waser B, Reubi JC. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications. Endocrine-related cancer. 2009;16(2):623-633.
4. Ananias HJ, van den Heuvel MC, Helfrich W, de Jong IJ. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer. The Prostate. 2009;69(10):1101-1108.
5. Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). Clin Cancer Res. 2002;8(4):1139-1146.
6. Sun B, Halmos G, Schally AV, Wang X, Martinez M. Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers. The Prostate. 2000;42(4):295-303.
9. Vlachostergios PJ, Niaz MJ, Sun M, et al. Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer. Frontiers in oncology. 2021;11.
PETALUMA, Calif., Oct. 3, 2023 /PRNewswire/ — Jump Aero, a California-based aviation manufacturer building the world’s fastest sustainable personal aircraft, and the Utah Department of Transportation-Division of Aeronautics have agreed to collaboratively determine what full coverage of the state with Jump Aero’s flight-based first responder operations would entail. The MOU, signed earlier this month, sets the stage for Utah to determine how many Jump JA-1 Pulse personal electric vertical takeoff and landing (eVTOL) aircraft it would need to acquire in order to provide life-saving response times throughout the state and how best to structure future collaboration between Jump Aero and Utah’s existing first response organizations.
Utah is particularly well-suited to benefit from the JA-1 Pulse as it is a state with many remote and rural communities and that welcomes a large influx of tourists to its numerous remote and hard to access natural attractions. In many areas, ambulance arrival and first response times can be well beyond what is considered necessary to support positive outcomes due to distances and terrain. By enabling skilled first responders to fly directly to the scene of the emergency, Jump Aero’s platform can save lives of both Utah’s residents and visitors.
The signed MOU brings the relationship between Jump Aero and the State of Utah to a new level, bringing both parties closer to the goal of getting medical professionals to the scene of an emergency as quickly as possible. Paul Damron, Advanced Air Mobility Manager, UDOTs Division of Aeronautics, shared his excitement regarding this development, stating:
“We have been following Jump Aero’s progress for a number of years and are excited to formalize a working relationship to bring this technology to Utah.” Jump Aero President and CEO Carl Dietrich added that “It is incredibly gratifying to now have an official way in which we can work with the State and their expert first responders to bring the JA-1 and its life saving potential to the people of Utah. We are looking forward to continuing to build a long-term relationship with Utah and to providing them with this advanced emergency response capability into the future.”
The JA1 Pulse can fly one trained professional plus emergency equipment to unimproved landing zones in rural areas. More detail about the aircraft is available at: www.jumpaero.com
About Jump Aero Jump Aero Incorporated is an advanced air mobility company with a mission to leverage electric vertical takeoff and landing (eVTOL) aircraft technology to help save lives by reducing emergency response times in rural areas. Jump Aero is headquartered in Petaluma, California with satellite offices in Santa Paula, California and Chelsea, Massachusetts.
About UDOT Division of Aeronautics The primary purpose of the Aeronautics Division is to lead and manage a statewide transportation system of airports, aircraft, and air routes. The Division of Aeronautics promotes the quality of life framework established by the UVision for good health, better mobility, a strong economy, and connected communities.
